GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareRx Corp (TSX:CRRX) » Definitions » EV-to-EBIT

CareRx (TSX:CRRX) EV-to-EBIT : 45.60 (As of May. 13, 2024)


View and export this data going back to 2009. Start your Free Trial

What is CareRx EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CareRx's Enterprise Value is C$212.5 Mil. CareRx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$4.7 Mil. Therefore, CareRx's EV-to-EBIT for today is 45.60.

The historical rank and industry rank for CareRx's EV-to-EBIT or its related term are showing as below:

TSX:CRRX' s EV-to-EBIT Range Over the Past 10 Years
Min: -1198.96   Med: -10.8   Max: 120.87
Current: 45.6

During the past 13 years, the highest EV-to-EBIT of CareRx was 120.87. The lowest was -1198.96. And the median was -10.80.

TSX:CRRX's EV-to-EBIT is ranked worse than
86.68% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.19 vs TSX:CRRX: 45.60

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. CareRx's Enterprise Value for the quarter that ended in Dec. 2023 was C$187.2 Mil. CareRx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$4.7 Mil. CareRx's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.49%.


CareRx EV-to-EBIT Historical Data

The historical data trend for CareRx's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareRx EV-to-EBIT Chart

CareRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.77 -9.35 -38.86 -11.48 40.03

CareRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.48 -11.27 57.69 45.77 40.03

Competitive Comparison of CareRx's EV-to-EBIT

For the Medical Care Facilities subindustry, CareRx's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareRx's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareRx's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CareRx's EV-to-EBIT falls into.



CareRx EV-to-EBIT Calculation

CareRx's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=212.477/4.66
=45.60

CareRx's current Enterprise Value is C$212.5 Mil.
CareRx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$4.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareRx  (TSX:CRRX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CareRx's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=4.66/187.163071
=2.49 %

CareRx's Enterprise Value for the quarter that ended in Dec. 2023 was C$187.2 Mil.
CareRx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$4.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareRx EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CareRx's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CareRx (TSX:CRRX) Business Description

Traded in Other Exchanges
Address
320 Bay Street, Suite 1200, Toronto, ON, CAN, M5H 4A6
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education, and medication system quality and efficiency. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
Executives
Kevin Dalton Director

CareRx (TSX:CRRX) Headlines

No Headlines